StonvexLoading…
StonvexStonvexStonvexCore line items from TU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | C$20.51B | C$20.39B | C$20.12B | C$18.41B |
Operating Income | C$2.36B | C$2.80B | C$2.36B | C$2.95B |
Net Income | C$777.00M | C$938.00M | C$867.00M | C$1.72B |
EPS (Diluted) | C$0.72 | C$0.67 | C$0.58 | C$1.15 |
Total Assets | C$59.61B | C$58.03B | C$56.14B | C$54.07B |
Total Liabilities | C$43.03B | C$41.23B | C$38.83B | C$36.41B |
Cash & Equivalents | C$2.62B | C$869.00M | C$864.00M | C$974.00M |
Free Cash Flow OCF − CapEx | C$2.14B | C$2.21B | C$1.88B | C$1.52B |
Shares Outstanding | Not available | Not available | Not available | Not available |